Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial-Reference-Cited by-同舟云学术

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial

Published:2016-04 Issue:4 Volume:15 Page:365-372
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Privitera Michael D,Welty Timothy E,Gidal Barry E,Diaz Francisco J,Krebill Ron,Szaflarski Jerzy P,Dworetzky Barbara A,Pollard John R,Elder Edmund J,Jiang Wenlei,Jiang Xiaohui,Berg Michel

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference25 articles.

1. Study on requirements of bioequivalence for registration of pharmaceutical products in USA, Europe and Canada;Galgatte;Saudi Pharm J,2014

2. Generic drugs: caveat emptor! (and other advice from cyberspace);Reisman;P T,2010

3. Generic and therapeutic substitutions in the UK: are they a good thing?;Duerden;Br J Clin Pharmacol,2010

4. Generic substitution in the treatment of epilepsy: patient and physician perceptions;Berg;Epilepsy Behav,2008

5. Antiepileptic drugs: generic versus branded treatments;Heaney;Lancet Neurol,2007

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact and implications of national centralized drug procurement in China;International Journal of Clinical Pharmacy;2024-07-11

2. Lamotrigine add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2023-12-11

3. Safety of brand name to generic substitution of lacosamide in patients with epilepsy - A prospective single-center observational study;Seizure: European Journal of Epilepsy;2023-10

4. Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region;Neurology and Therapy;2023-05-24

5. Brand Name Versus Generic?;Epilepsy Currents;2023-03-30